
Retatrutide
Triple-receptor research · GLP-1, GIP & glucagon
U.S.-based research company
Free peptide research summaries: key studies, current FDA status and the original sources, all in one place. Plus custom research for physicians, med spas and licensed practitioners.
Explore the research libraryFree to read. No account needed.
Send a research request
Choose a subject. Find your starting point.
Follow a subject through the library. Each area brings together the compounds, their key studies, current FDA status and the limits of the evidence.
The research collection
Meet the compounds. Read their key studies. Send your question directly to our team.

Triple-receptor research · GLP-1, GIP & glucagon

BPC-157 + GHK-Cu + TB-500

Cellular energy coenzyme · Not a peptide
Research updates
New trials, publications and FDA decisions for the compounds in our library. Checked November 7, 2026.
Lilly presents TOGETHER-PsA, a phase 3b study of ixekizumab with tirzepatide in psoriatic arthritis with obesity.
Read the sourceLilly presents the 68-week phase 3 TRIUMPH-4 trial in knee osteoarthritis pain as a plenary; knee data from TRIUMPH-1 follow on November 10.
Read the sourceSponsor-reported TRANSCEND-T2D-2 results compare retatrutide with semaglutide 2 mg in type 2 diabetes over 80 weeks. Full results are not yet published.
Read the sourceHHS published an enforcement-discretion policy covering BPC-157, epitalon, KPV, MOTS-c, Semax and TB-500 for licensed pharmacies and physicians. Comments close November 13, 2026.
Read the sourceHow research requests work
Physicians, med spas and licensed practitioners tell us what they are researching. We find, read and summarize the most trusted literature, so they don’t have to.
500+ clients served
Send a research requestTell us the compound and what you want to learn from the research. A short note is enough.
Our team replies by email or phone, usually within 1–24 hours, to confirm exactly what you need.
Custom research is a paid service. We confirm the scope and fee with you before any work starts.
Clarity, all the way to the source
Human trials first, then reviews, then laboratory work. Every finding is linked to its source, with its limits in view.
Our methodologyClear answers
Anyone can read the research library. Our custom research clients are physicians, nurse practitioners and PAs, med spas, licensed practitioners and researchers.
We confirm what you need, then find and summarize the most relevant studies and regulatory records for your question. Custom research is a paid service, and we confirm the scope and fee with you first.
Usually within 1–24 hours, by email or phone, whichever you prefer.
No. We publish research summaries and prepare research for professionals. We don’t sell or ship any physical product.
Our Los Angeles office is open by appointment only. Contact the team to arrange a visit.
Office address and contact →Stay connected to the research
New trials, publications and FDA decisions for the compounds in our library, sent by email. Unsubscribe any time.
We use your email only to send what you choose here. Joining the list is not a giveaway entry.
Direct to our team
Tell us the compound and what you want to understand. Our team follows up by email or phone, usually within 1–24 hours.